NCT03383523View on ClinicalTrials.gov

Relative Bioavailability Study of Emodepside IR-tablets and Solution

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

March 26, 2018

Study Completion Date

March 26, 2018

Conditions
Filariasis
Interventions
DRUG

Emodepside (BAY 44-4400)

2 tablets compared to the liquid formulation

Trial Locations (1)

NW10 7EW

Hammersmith Medicines Research (HMR) Limited, London

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Drugs for Neglected Diseases

OTHER